Get started
Author

MMRF Immune Atlas Network

OpenAlex ID: A5120636371
PA-446 Single Sample Prediction of Multiple Myeloma High-Risk Genomic Events Using Bulk and Single-Cell Gene Expression
2026 · Steven Foltz, Jaclyn Taroni, et al. · Clinical Lymphoma Myeloma & Leukemia
PA-251 IMS/IMWG CGS Risk Stratifies Terminal T Cell Accumulation, Loss of B Cell Immunity, and Proliferative Tumor Transcriptional Programs in Rapidly Progressing Myeloma
2026 · William C. Pilcher, Denis J. Ohlstrom, et al. · Clinical Lymphoma Myeloma & Leukemia
PA-234 Immune Age Acceleration Predicts Early Progression in Transplant-Eligible Patients With Multiple Myeloma Independent of Frailty
2026 · Katherine Ferguson, William Pilcher, et al. · Clinical Lymphoma Myeloma & Leukemia
PA-465 Stem-like CD8+ Memory Effector T Cells Are Prognostic and Predictive of Response in Transplant-Eligible Newly Diagnosed Patients Receiving VRd and Autologous Stem Cell Transplant
2026 · Chaitanya Acharya, MMRF Immune Atlas Network, et al. · Clinical Lymphoma Myeloma & Leukemia
Combinations of high risk cytogenetic events in multiple myeloma drive distinct immune remodeling patterns and worse outcomes
2025 · William Pilcher, Marina Michaud, et al. · Blood
PDF
An immune proteomic atlas of 300 million bone marrow cells reveals prognostic cell states in multiple myeloma
2025 · Dimitra Karagkouni, Shivani Nanda, et al. · Blood
Works count: 6
Citation count:
H-index:
I10-index:
Year
Topic
Type